市場調查報告書
商品編碼
1380257
全球高級視覺化市場 2023-2030Global Advanced Visualization Market 2023-2030 |
全球高階視覺化市場根據產品和服務、解決方案類型、影像模式和臨床應用進行細分。根據產品和服務,市場分為硬體、軟體和服務。根據解決方案類型,市場分為企業版和獨立版。根據影像方式,市場分為磁振造影(MRI)、電腦斷層掃描(CT)、超音波、核子醫學和其他影像方式。根據臨床應用,市場分為腫瘤學、骨科、心血管、神經病學和其他臨床應用(牙科)。
想像力對於癌症檢測和腫瘤科有效實施放射治療至關重要。因此,先進的可視化技術使醫生能夠儘早診斷癌症。不同癌症的盛行率不斷上升,以及先進視覺化工具技術的不斷進步,推動了醫療機構中先進視覺化工具的採用,進而推動了該細分市場的成長。
根據國際癌症研究機構 (IARC) 2021 年 7 月的更新估計,到 2040 年,全球癌症負擔預計將增加至 2,750 萬新癌症病例和 1,630 萬人死亡。如此高的負擔將增加對先進可視化的需求,因為它將在識別與癌症盛行率和治療相關的趨勢方面提供顯著的好處。
全球高級視覺化市場根據地理位置進一步細分,包括北美(美國和加拿大)、歐洲(義大利、西班牙、德國、法國等)、亞太地區(印度、中國、日本、韓國等)其他)以及世界其他地區(中東、非洲和拉丁美洲)。預計亞太地區將成為全球市場中成長最快的地區。該區域市場的推動因素包括龐大的患者群體、醫療保健設施的技術進步以及醫院擴大採用先進的軟體和服務。
2023 年7 月,ConcertAI 公司Tera Recon 宣布擴大其在澳洲與Change Healthcare 的經銷商和服務協議。Change Healthcare 是一家醫療保健IT 供應商,提供創新解決方案以幫助改善醫療保健之旅,並為全球3,500多家診斷影像提供者提供服務。根據擴大後的協議,Change Healthcare 將成為 Intuition 在澳洲的獨家經銷商,Intuition 是 TeraRecon 與供應商無關的黃金標準高級視覺化解決方案。這些發展進一步促進了區域市場的成長。
該區域市場的推動力是醫療保健環境中先進軟體和服務的廣泛採用,以提供品質的醫療保健。採取不同成長策略的主要市場參與者的存在進一步推動了區域市場的成長。例如,2022 年 11 月,Ziosoft 為其位於芝加哥的旗艦 Ziostation 系統引入了 revoras 平台。 Revoras 平台(正在進行中)提供了許多生產力增強功能和新的視覺化技術,包括獨特的 Ziosoft Rembrandt 影像渲染功能。除了 Rembrandt 觀看功能之外,Revoras 平台還提供複雜的協議工作流程,透過加速自動化來加快處理速度並減少培訓負擔,從而使工作流程變得更加簡單。 Revoras 利用平台內人工智慧的力量來最佳化可重複的結果,幫助更快實現改變生活的治療。
服務全球先進視覺化市場的主要公司包括: Fujifilm Holdings Corp.、Koninklijke Philips NV、Agfa-Gevaert Group、Canon Medical Systems Corp.)、通用電氣公司(GE Healthcare)等。市場參與者透過各種策略(包括併購、合作、合作、融資和新產品發布)為市場成長做出巨大貢獻,以維持市場競爭力。例如,2023 年 7 月,美國先進視覺化軟體供應商 Mirada Medical 擴大了其嵌入式合作夥伴計劃,涵蓋了世界上第一個成像 EMR OmegaAI 的開發商 RamSoft。與Mirada 的合作意味著RamSoft 的客戶已融入全球數千名醫療保健專業人員中,他們目前利用多模態和圖像配準工具為用戶提供無與倫比的用戶體驗,並透過先進的直覺式介面存取更多成像資料。
Title: Global Advanced Visualization Market Size, Share & Trends Analysis Report by Product and Service (Hardware, Software, and Services), by Solution Type (Enterprise and Standalone), by Imaging Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, Nuclear Medicine, and Other Imaging Modalities), and by Clinical Application (Oncology, Orthopedics, Cardiovascular, Neurology, and Other Clinical Applications (Dental)),Forecast Period (2023-2030).
Global advanced visualization market is anticipated to grow at a significant CAGR of 11.0% during the forecast period. The increasing prevalence of chronic diseases coupled with the growing geriatric population and rising awareness of the benefits associated with advanced visualization tools in disease diagnosis are the key factors driving the growth of the global advanced visualization market. Additionally, the advancements in advanced visualization tools are further contributing to the global market growth. For instance, in October 2022, Align Technology, Inc. introduced iTero-exocad Connector, which integrates iTero intraoral camera and NIRI images within exocad DentalCAD 3.1 Rijeka software. This new integration optimizes design and fabrication of highly esthetic restorations by providing the ability for dental professionals to visualize the internal and external structure of teeth. However, the lack of medical reimbursements for radiology-based diagnostic procedures is restraining the market growth.
The global advanced visualization market is segmented based on product and services, solution type, imaging modality, and clinical application. Based on products and services, the market is segmented into hardware, software, and services. Based on solution type, the market is segmented into enterprise and standalone. Based on imaging modality, the market is segmented into Magnetic Resonance Imaging (MRI), Computed Tomography (CT), ultrasound, nuclear medicine, and other imaging modalities. Based on clinical application, the market is segmented into oncology, orthopedics, cardiovascular, neurology, and other clinical applications (dental).
Imagining is crucial in cancer detection and for the effective delivery of radiation treatment in oncology departments. Hence, advanced visualization technology enables physicians to diagnose cancers in the earliest stage possible. The growing prevalence of different cancers along with rising technological advancements in advanced visualization tools has driven the adoption of advanced visualization tools in healthcare facilities, which in turn driving the growth of this market segment.
According to estimates from the International Agency for Research on Cancer (IARC) updates from July 2021, by 2040, the global burden of cancers is expected to grow to 27.5 million new cancer cases and 16.3 million mortality globally. Such high burdens will increase the demand for advance visualization as it would provide significant benefits in identifying the trend related to the prevalence and treatment of cancer.
The global advanced visualization market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Asia-Pacific is anticipated to exhibit the highest growth in the global market. The regional market is driven by the presence of a huge patient pool, technical advancement in healthcare facilities, along with the growing adoption of advanced software and services in hospitals.
In July 2023, Tera Recon, a ConcertAI company has announced the expansion of its reseller and service agreement in Australia with Change Healthcare, a healthcare IT provider that delivers innovative solutions to help improve the healthcare journey and serves more than 3,500 diagnostic imaging providers internationally. Under the expanded agreement, Change Healthcare will serve as the sole distributor in Australia for Intuition, TeraRecon's vendor-agnostic, gold standard, advanced visualization solution. Such developments are further contributing to the regional market growth.
The regional market is driven by the high adoption of advanced software and services in healthcare settings to offer quality healthcare. The presence of key market players that are adopting different growth strategies is further driving the regional market growth. For instance, in November 2022, Ziosoft has introduced revoras platform for its flagship Ziostation system in Chicago. The Revoras platform (work in progress) offers numerous productivity enhancements and new visualization technology including the unique Ziosoft Rembrandt image rendering capability. In addition to the Rembrandt viewing capability, the Revoras platform provides complex protocol workflows, which are made simpler using accelerated automation for faster processing and reduced training burdens. Revoras harnesses the power of AI within the platform to optimize the reproducible results, helping to enable life-changing therapies faster.
The major companies serving the global advanced visualization market include: Fujifilm Holdings Corp., Koninklijke Philips N.V., Agfa-Gevaert Group, Canon Inc. (Canon Medical Systems Corp.), General Electric Company (GE Healthcare) among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2023, Mirada Medical, the US based advanced visualization software provider has expanded its embedded partnership program to include RamSoft, developer of the world's first Imaging EMR, OmegaAI. The partnership with Mirada signifies the incorporation of RamSoft customers to the thousands of global healthcare professionals who currently utilize multimodality and image registration tools geared to provide users with an incomparable user experience and access to more imaging data via an advanced intuitive interface.